Serological response to COVID-19 vaccine and its predictors in patients with solid malignancies: a systematic review and meta-analysis of 16 cohort studies | NITAG RESOURCE CENTER

Rating:

Critically low

Authors:

Chen, D.

Pan, Y.

Wang, Y.

Chen, X.

Zhang, J.

Zhang, Y.

Ding, T.

Yang, Z.

Lu, T.

Zheng, Y.

Wei, J.

Kong, W.

Li, H.

Yin, X.

Yang, G.

Zhang, G.

Wang, X.

Disease:

COVID-19

Methodological quality (AMSTAR 2):

Critically low

Source(s):

https://doi.org/10.1016/j.jinf.2022.11.012

Open access:

Yes

Date of last literature search:

Sep 2022

Number of studies:

16

Publication year:

2022

Abstract

Adults
Older adults
COVID-19
Efficacy/effectiveness